Aptiv and Vecna Robotics to Develop Next Generation Autonomous Mobile Robots
Aptiv PLC (NYSE: APTV), a global industrial technology leader, and Vecna Robotics, a pioneer in AI-driven autonomous material handling solutions, today announced a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions designed to deliver cost-efficient automation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218958100/en/
Aptiv’s advanced perception portfolio and machine learning technologies will be integrated into Vecna Robotics’ platform.
This partnership combines Aptiv’s industry-leading portfolio, with Vecna Robotics’ advanced autonomy and orchestration platform to provide safer, more efficient, and scalable material handling systems.
“Automation is transforming the way goods move through warehouses and factories, with devices that sense, think and act in real time,” said Javed Khan, Executive Vice President, Intelligent Systems, Aptiv. “Our collaboration with Vecna Robotics combines Aptiv’s advanced perception, compute, and software solutions with Vecna’s proven expertise in autonomous material handling. Together, we’re making automation safer, smarter, and more affordable—helping customers meet the demands of modern logistics.”
As part of this collaboration, Aptiv’s advanced perception portfolio and machine learning technologies will be integrated into Vecna Robotics’ platform, delivering reliable, cost-efficient automation at scale across industrial environments. The joint solution combines several key capabilities:
Perception and Sensing Hardware – Award-winning PULSE™ Sensor – a compact, surround-view camera paired with an ultrashort-range radar, enabling reliable and accurate 360-degree sensing.
ML Based Real-Time Perception and Path Planning – Aptiv Radar ML and Behavior ML deliver advanced machine learning technologies for real-time perception and dynamic path planning in complex environments.
Autonomy and Workflow Orchestration – The Vecna Robotics platform, equipped with advanced perception and fail-safe navigation systems, prioritizes workplace safety by detecting and avoiding obstacles in real time—even in mixed-traffic environments. Beyond autonomy, Vecna’s unique CaseFlow™ integration enables seamless orchestration of workflows across humans, forklifts, and other automation systems, ensuring optimized throughput without disrupting existing operations.
Aptiv’s Embedded Software and Compute – Built on Aptiv's scalable, efficient and high-performance compute platform—including the VxWorks real-time operating system (RTOS) and Wind River® Helix™ Virtualization Platform—this solution delivers best-in-class performance, advanced virtualization, ultra-low latency, and exceptional flexibility to support a wide range of system designs.
Vecna Robotics delivers flexible, intelligent automation through advanced AMRs that adapt to dynamic warehouse and factory environments. Powered by AI-driven autonomy and the Pivotal™ orchestration platform, Vecna’s solutions coordinate people, robots, and workflows to optimize material flow in real time—without requiring costly or rigid infrastructure. Its platform accelerates deployment, scales easily across operations, and consistently delivers measurable improvements in throughput, safety, and operational efficiency.
“Partnering with Aptiv enables us to deliver even more robust and cost-optimized robotic products,” said Karl Iagnemma, CEO, Vecna Robotics. “This collaboration strengthens our ability to help customers reduce operational costs, improve throughput, and achieve faster, more scalable automation ROI. By combining our AI-driven autonomy and orchestration with Aptiv’s advanced perception and compute technologies, we’re enabling more efficient workflows, safer operations, and meaningful cost savings for customers seeking to modernize without major infrastructure investment.”
Together, Aptiv and Vecna Robotics are redefining what’s possible in autonomous material handling—combining advanced perception, compute, and orchestration to deliver automation that is safer, smarter, and built to scale. This partnership equips customers with a more powerful, cost-effective foundation for the future of industrial operations.
Aptiv will showcase Vecna Robotics’ CPJ Co-Bot Pallet Jack in its pavilion at CES 2026.
About Aptiv
Aptiv is a global industrial technology company focused on enabling a more automated, electrified, and digitalized future. Visit aptiv.com.
About Vecna Robotics
Vecna Robotics’ flexible material handling AMRs and PivotalTM software platform boost throughput, reduce labor strain, and deliver fast ROI without fixed infrastructure. Visit https://www.vecnarobotics.com/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251218958100/en/
Contacts
Ariel Gavilan
Vice President of Global Communications, Aptiv
ariel.gavilan@aptiv.com
248-251-3447
Alex Miller
vecnarobotics@marketbridge.com
832-564-9966
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press Release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press Release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press Release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press Release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press Release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom